3,4-Dihydro-3-methyl-4-oxo-pyrazolo<5,1-d>-1,2,3,5-tetrazin-8-carbonsaeure-ethylester | 73997-10-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3,4-Dihydro-3-methyl-4-oxo-pyrazolo<5,1-d>-1,2,3,5-tetrazin-8-carbonsaeure-ethylester
• 英文别名: 3-methyl-4-oxo-3,4-dihydro-pyrazolo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid ethyl ester；8-Carbethoxy-3-methylpyrazolo<5,1-d><1,2,3,5>tetrazin-4-on；Ethyl 3-methyl-4-oxopyrazolo[5,1-d][1,2,3,5]tetrazine-8-carboxylate
• CAS: 73997-10-1
• 化学式: C₈H₉N₅O₃
• 分子量: 223.191
• InChiKey: YWSKAMFYVCIPPW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  89.2
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  3-氨基-4-乙氧羰基吡唑 、 异氰酸甲酯 生成 3,4-Dihydro-3-methyl-4-oxo-pyrazolo<5,1-d>-1,2,3,5-tetrazin-8-carbonsaeure-ethylester
  参考文献：
  名称：

  Ege, Guenter; Gilbert, Karlheinz; Maurer, Kurt, Chemische Berichte, 1987, vol. 120, p. 1375 - 1396

  摘要：

  DOI：

文献信息

• Tetrazines
  申请人：MAY & BAKER LIMITED

  公开号：EP0252682A2

  公开（公告）日：1988-01-13

  Tetrazines of the formula: wherein R¹ represents cycloalkyl, optionally substituted alkyl, alkenyl or alkynyl, A¹ represents nitrogen or -CR³= wherein R³ represents hydrogen or a substituent, A² represents nitrogen or, when A¹ represents nitrogen, A² represents nitrogen or a group -CR³= as hereinbefore defined, Z¹ represents oxygen or sulphur, and R² represents a cyano or azidocarbonyl group or a group of the formula -COZ²R⁹, -CONHOR⁹, -CONHNR⁹R¹⁰, -CONHNHCOOR⁹, -CONHNHCONHR⁹ -COCR¹¹=N₂, -CONHR¹² or -CON=S(O)R¹³R¹⁴ wherein Z² is oxygen or sulphur and R⁹ and R¹⁰ each represents hydrogen, alkyl which may carry an optionally substituted phenyl substituent, or represents optionally substituted phenyl, R¹¹ represents hydrogen or alkyl, and R¹² represents optionally substituted alkyl and R¹³ and R¹⁴ each represent alkyl, and when R¹, R², or R³ represents or contains an acidic group, salts thereof are useful as pharmaceuticals; processes for their preparation and new intermediates are described.

  式中的四嗪： 其中 R¹ 代表环烷基、任选取代的烷基、烯基或炔基，A¹ 代表氮或-CR³= 其中 R³ 代表氢或取代基，A² 代表氮或当 A¹ 代表氮时、Z¹ 代表氧或硫，R² 代表氰基或叠氮羰基或式-COZ²R⁹、-CONHOR⁹、-CONHNR⁹R¹⁰、-CONHNHCOOR⁹、-CONHNHCONHR⁹ -COR¹=N₂的基团、-CONHR¹²或-CON=S(O)R¹³R¹⁴，其中 Z² 是氧或硫，R⁹和 R¹⁰ 各自代表氢、可带有任选取代的苯基取代基的烷基或代表任选取代的苯基、 R¹¹代表氢或烷基，R¹²代表任选取代的烷基，R¹³和R¹⁴各自代表烷基，当R¹、R²或R³代表或含有酸性基团时，其盐可用作药物；描述了其制备工艺和新的中间体。
• EGE, GUNTER;GILBERT, KARLHEINZ;MAURER, KURT, CHEM. BER., 120,(1987) N 8, 1375-1395
  作者：EGE, GUNTER、GILBERT, KARLHEINZ、MAURER, KURT

  DOI：——

  日期：——
• Ege, Guenter; Gilbert, Karlheinz; Maurer, Kurt, Chemische Berichte, 1987, vol. 120, p. 1375 - 1396
  作者：Ege, Guenter、Gilbert, Karlheinz、Maurer, Kurt

  DOI：——

  日期：——